Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Najar Medical and Invention AB
AB
Active
Org 5568565039
Lågspänningsgatan 9, 721 37
Västerås
Business and other management consultancy activities
· NACE 7020
Est. 2011
0 employees
Watchlist
Share
Sweden
/
Companies
/
Business and other management consultancy activities
/
Najar Medical and Invention AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
1M
1M
2M
2M
2M
2021
2M
2022
1M
2023
1M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
1M
2021
1M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
1 557
2 088
564
724
0
Staff expenses
—
−539
−519
−264
−0
EBITDA
789
844
−1
358
−35
Depreciation & amort.
−33
−8
—
—
—
EBIT
756
836
−1
358
−35
Net financials
—
—
3
−5
4
Profit before tax
717
761
108
706
9
Tax
−162
−161
15
−160
−6
Net profit
555
600
123
546
2
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
10 578
11 596
10 861
11 730
11 386
Equity
8 631
9 051
8 994
9 540
9 543
Long-term debt
0
—
—
—
—
Short-term debt
330
853
280
956
649
Total debt
330
853
280
956
649
Financial ratios
5-year trend
EBITDA margin
-3475000.0%
This company
15.8%
Market median
-21993771% vs market
2021
2025
Equity ratio
83.8%
This company
38.2%
Market median
+119% vs market
2021
2025
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
2021
2025
Net profit margin
241500.0%
This company
8.1%
Market median
+2981381% vs market
2021
2025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2021
2025
Debt / equity
0.19×
This company
0.62×
Market median
+69% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
View
PDF
More on Najar Medical and Invention AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
